396.74 USD
▼-1.34-0.34%
盘后 398.88 0.00%
2026-11-19
市值
$9.06B
市盈率
—
EPS
-6.74
股息率
—
52 周区间
353.54 – 615.00
成交量
416.64K
Beta
-1.00
目标价
688.78
52W 低 353.5452W 高 615.00
价格走势
公司简介
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.